{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Is CryoPort, Inc. technically bullish or bearish?
As of June 17, 2025, the technical trend is neutral with mixed signals, showing mild bullishness in longer-term indicators but caution is advised due to short-term bearishness.
Who are in the management team of CryoPort, Inc.?
As of March 2022, the management team of CryoPort, Inc. includes Jerrell Shelton (Chairman, President, CEO), Richard Berman (Lead Independent Director), Daniel Hancock, Ram Jagannath, Robert Hariri, and Ramkumar Mandalam (all Directors).
What does CryoPort, Inc. do?
CryoPort, Inc. is a life sciences services company focused on supply chain solutions for biopharma, reproductive medicine, and animal health markets. As of March 2025, it reported net sales of $41 million and a net loss of $9 million, with a market cap of $337.92 million.
How big is CryoPort, Inc.?
As of Jun 18, CryoPort, Inc. has a market capitalization of 337.92 million and reported net sales of 214.83 million with a net profit of -104.89 million over the last four quarters. Shareholder's funds are 401.90 million, and total assets amount to 703.49 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
